Rehmann Capital Advisory Group’s Ionis Pharmaceuticals IONS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$23.5K	Sell	392 -200	-34%	-$13K	﹤0.01%	828
2019 Q2	$38K	Buy	592 +173	+41%	+$12.2K	﹤0.01%	936
2019 Q1	$34K	Hold	419	–	–	﹤0.01%	949
2018 Q4	$22.7K	Sell	419 -47	-10%	-$2.4K	﹤0.01%	826
2018 Q3	$24K	Sell	466 -210	-31%	-$9.87K	﹤0.01%	1059
2018 Q2	$28.2K	Sell	676 -35	-5%	-$1.55K	﹤0.01%	988
2018 Q1	$31K	Buy	+711	New	+$36.1K	﹤0.01%	923

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rehmann Capital Advisory Group's IONS Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Ionis Pharmaceuticals (IONS) stake by 34% in Q3 2019, selling an estimated $13K and leaving 392 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Rehmann Capital Advisory Group first reported a position in IONS in Q1 2018 and has held it in 7 quarters since. The position peaked at $38K in Q2 2019. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

Rehmann Capital Advisory Group held 392 shares of Ionis Pharmaceuticals worth $23.5K as of Q3 2019.
Rehmann Capital Advisory Group sold 200 Ionis Pharmaceuticals shares in Q3 2019, an estimated $13K.
Ionis Pharmaceuticals made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #828 holding.
Rehmann Capital Advisory Group first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
Rehmann Capital Advisory Group's Ionis Pharmaceuticals position peaked at $38K in Q2 2019.
369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.